Using a tracer injection technic, modified to provide accurate and repeated determinations of cardiac output in the ambulatory patient, the authors have shown that chronic pentolinium therapy for hypertension lowers blood pressure by reducing cardiac output in the seated position. From these observations and the work of others, they believe that the effect of ganglionic blockade on venoconstrictor tone deserves greater emphasis.
they describe. Pritchard's method was further modified as follows: 1. The RISA-containing syringe was weighed before and after injection to determine accurately the quantity of isotope injected. 2. A flushing syringe containing 10 ml. of normal saline was attached by a T connection and a 1-way valve to propel more rapidly the bolus of injected substance. 3. Individual brachial artery samples were collected every 2 sec. by means of a circular test tube rack placed on a simple rotating stool and moved by hand, in time with the clicks of a metronome set at 60 beats/min. 4. Representative samples were pipetted into radioactively clean test tubes and counted individually in an iodine crystal-type well scintillation counter.* The measured samples were compared to known dilutions of the stock RISA solution injected. Each sample and standard was counted for 6400 or more counts, which gives a theoretical counting error of 1.25 per cent or less in each sample. The cardiac output was calculated from Hamilton's formula,5 the curves being plotted on semilogarithmic paper extrapolated to 0 to exclude recirculated test substance. The formula used was Cardiac Total counts injected X 60 1 output -Sum of counts/sec./ml. at each 1 1000 (L./min.) sec. interval as determined under the extrapolated curve Mean circulation time was calculated from the formula,
MCT -E (C. t) SC
where C equals the counts per second at the time t and t equals the time interval (in seconds) from the time of injection to the time at which concentration was measured. Using these figures, pulmonary blood volume was calculated from the formula, PB-= Cardiac output (ml/niin.) X MCT 60 as described by Hamilton fig. 1 ).
Values for (ardiac index fell in all patients, DISCUSSION The reductions in cardiac output and stroke volume noted in the sitting position after acute or chronic ganglionic blockade confirm the clinical impression of increased fatigue and weakness associated with this form of blood pressure depression. Failure of cardiac output to improve after long intervals of treatment is also confirmed by clinical experience; the patient who had been under treatment for 14 months noted improved strength when the drug was discontinued and the cardiac output and blood pressure rose. Despite these observations, we believe that pentolinium and other ganglionic-blocking agents perform a useful role in severe hypertension, both by reducing the arterial lesions that may follow sustained arterial hypertension but also by their effects on the heart, which undergoes a great reduction in work load, and on the lungs, which lose blood volume to the systemic circulation, as is shown by the regular reduction in pulmonary blood volume noted in these studies. A shift of 300 ml. of blood from lung to periphery could be very advantageous if pulmonary edema were incipient. Werko9 also noted reductions in pulmonary blood volume in the recumbent position after ganglionic blockade. We are unable to explain the contrary observations of Gilmore and associates,10 although they used a different method of calculating pulmonary blood volume.
The reduction in cardiac output in the seated posture appears to account entirely for the decline in blood pressure that is seen acutely or chronically. As stated previously, there are no comparable studies on the effects of chronic administration of ganglionic-blocking agents on cardiac output, and only a few observations of the acute effects of these agents in the orthostatic position. These latter are difficult to compare with our own observations. The studies of Gilmore and associates'0 in 4 patients using the direct Fick procedure showed "no accentuation of the usual reduction in cardiac output after tilting when the patient had been given C-6." Hickam and Pryor,"1 studying the cardiac output of 12 patients with postural hypotensive disease, recorded a reduction in output when they were tilted to 600, which was usually no greater than that observed in the normal subject. When a large amount of albumin in saline solution was infused, the cardiac output increased and the blood pressure in some cases was maintained after tilting. This suggested "that these large output falls resulted from an inadequate venous return to the heart." It is to be noted that these 2 studies quoted are not strictly comparable to our own, since the patients were not studied in the sitting or tilted position both before and after ablation of neurogenic tone.
In the present study it is difficult to escape the conclusion that ganglionic blockade did not reduce arteriolar tone but acted upon the cardiac output through a reduction in venous return to the heart, as suggested for some of Hickam's cases. This theory would best explain the observations of Restall and Smirk12 that immersion in water exactly cancels the effect of ganglionic blockade. The increase in tissue pressure so produced would hardly be of sufficient magnitude to reduce the lumen of arterioles, which normally maintain pressures greatly in excess of the pressure in the water bath, but such external pressure would be expected to correct exactly that decrement in peripheral venous pressure gradient brought about by the imposition of the force of gravity, and thus to "set" venous return, blood flow, and cardiac output at a new level. The decline of pulmonary blood volume noted in this study and in that of Werko and associates9 can be explained on the basis of a peripheral shift of blood as a result of a new balance between pulmonary and peripheral arterial blood pres- Although the studies reported here do not necessarily apply to the effect of ganglionicblocking agents on the circulation in the recumbent patient, the importance of this subject in assessing "neurogenic" and "humoral" factors in hypertension13' 14 justifies an attempt to extend the present theory to the action of these agents in the resting recumbent subject. As reviewed by Doyle and Smirk,14 observations on cardiac output in the recumbent subject are in conflict, but a number of authors did not observe a change in the calculated peripheral arteriolar resistance when the drug was given intravenously to the recumbent hypertensive patient not in cardiac failure.'6-20 Crosley and co-workers20 demonstrated a consistent decrease in cardiac output and right atrial pressure with no change or an increase in total peripheral resistance when pentolinium was given intravenously to the recumbent hypertensive subject. Their experiments would conform with the observation that, except for the hands and feet, no vascular bed in the hypertensive subject can be demonstrated to have an increased blood flow after ganglionic blockade,21-23 and while vascular resistance falls in some of these areas, this occurs equally and pari passu with the blood pressure as if the vasodilatation were compensatory to the blood pressure fall rather than the primary factor in causing the reduction in blood pressure.
If noted by Bradley25 after hexamethonium. These observations suggest that the major site of action of ganglionic blockade is on venoconstrictor tone, perhaps by reducing the peripheral-to-central venous pressure gradient and thus causing a decrease in cardiac output and systemic blood pressure. This gradient, which maintains venous return to the heart, is reduced still further in the orthostatic position, and is improved by returning to the recumbent posture, by infusion of norepinephrine or angiotonin, which actively constricts peripheral veins, or by increasing tissue pressure with steroids or salt infusions; all procedures that have been claimed to introduce a "humoral factor" into the maintenance of the blood pressure.'3, 14 If neurogenic tone is considered to include particularly peripheral veins and venules, then we should agree with Doyle and Smirk'4 that the over-all blood pressure response to ganglionic blockade is a measure of pre-existing neurogenic tone. Since "neurogenic tone" is usually considered to apply chiefly to the arterioles, which regulate peripheral resistance, we wish to emphasize that ganglionicblocking agents may also affect blood pressure simply by altering neurogenic venous tone, and thus reduce blood pressure by reducing cardiac output. Such seems to be the mechanism of action in the patient with orthostatic hypotension induced by these agents.
SUMMARY
A method is presented for determining cardiac output with radioactive iodinated serum albumin that permits multiple serial determinations and involves relatively simple apparatus. The intravenous injection of depressor doses of pentolinium bitartrate to hypertensive patients in the sitting position resulted in a decline in cardiac output and no change in total peripheral resistance. Blood was shifted from the pulmonary to the peripheral circulation. Continued effective oral treatment with this agent over a period of 6 Two patients are described in whom cardiovascular manifestations accompanied metastasizing carcinoid. In 1, a 53-year-old man, diarrhea, "asthma," flushing attacks, and congestive heart failure accompanied biopsy-proven hepatic metastases whose origin was not identified. In the second patient, a 68-year-old woman, autopsy revealed extensive scarring and deformity of the valves of the heart in the following order of descending severity: pulmonic, tricuspid, mitral, aortic. An unusual feature that was thought to account for involvement of the valves on the left side was patency of the foramen ovale and right-to-left shunt. The presence of the last was attested to by the cyanosis and polycythemia present in life. These circumstances are consonant with the theory that the endocardial changes are produced directly by noxious substance(s) elaborated by the tumor, secreted into the blood stream, and partially destroyed in the lungs. The necessity for the presence of liver metastases suggests that the liver likewise destroys the noxious material. Another circumstance of the second case is the presence of only insignificant liver metastases, but of a huge metastasis to the ovary (which has its venous drainage directly to the vena cava) supports the view that the liver ordinarily destroys the noxious material, in part at least. In general, the behavior observed is that of serotonin, and a direct influence in the production of valvular lesions is suggested. Histologically, there were, in addition to chronic inflammatory changes, lesions with the appearance of platelet thrombi. Observations on a number of circulating patients are not available; the thrombocytosis observed in animals with injection of serotonin and in man with carcinoid tumor may have been present. MCKUSICK
